Abstract
Design: Using a mouse monoclonal antibody we developed, immunohistochemistry (IHC) was performed on ten WT cases along with matched normal kidney. We also performed Hace1 IHC on a tissue microarray (TMA) of 1378 interpretable breast cancer cases with associated prognostic data, including median follow-up time for non-relapsed patients of 9.5 years. Hace1 expression was scored separately for cytoplasmic and nuclear staining (0=negative; 1+=weak or <10% positive cells, 2+=strong >10% of cells, 3+=intense in >50% cells).
| Original language | English |
|---|---|
| Pages (from-to) | 341A-342A |
| Number of pages | 2 |
| Journal | Laboratory Investigation |
| Volume | 89 |
| Issue number | 1s |
| DOIs | |
| State | Published - Jan 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Immunohistochemical Study of Hace1 in Wilms' Tumor and Breast Cancer Suggests a Pro-Tumorigenic Role for Its Nuclear Isoform'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver